×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OSTX – os therapies incorporated (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OSTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
09:47 am
ostx
OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
High
Report
OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
11/4
07:00 am
ostx
OS Therapies to Present at The Spartan Capital Investor Conference
Low
Report
OS Therapies to Present at The Spartan Capital Investor Conference
10/30
08:51 am
ostx
Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30
Low
Report
Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30
10/28
04:44 pm
ostx
OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
Medium
Report
OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
10/24
08:46 am
ostx
OS Therapies to Present at the LD Micro Main Event XVII
Low
Report
OS Therapies to Present at the LD Micro Main Event XVII
10/17
09:22 am
ostx
OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Neutral
Report
OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
10/3
08:00 am
ostx
OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit
Medium
Report
OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit
9/13
08:09 am
ostx
OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
Low
Report
OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
Date
Time
Symbol
Company Name
Action
%Chg
11/15/2024
09:47 am
ostx
os therapies incorporated
MISS
Report
-12.0%
os therapies incorporated
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/15
04:05 pm
ostx
Form 8-K OS Therapies Inc For: Nov 15
Medium
Report
Form 8-K OS Therapies Inc For: Nov 15
11/15
09:15 am
ostx
Form 10-Q OS Therapies Inc For: Sep 30
Low
Report
Form 10-Q OS Therapies Inc For: Sep 30
11/14
05:00 pm
ostx
Form NT 10-Q OS Therapies Inc For: Sep 30
Medium
Report
Form NT 10-Q OS Therapies Inc For: Sep 30
11/1
05:00 pm
ostx
Form 8-K OS Therapies Inc For: Oct 31
Low
Report
Form 8-K OS Therapies Inc For: Oct 31
10/29
04:12 pm
ostx
Form 3 OS Therapies Inc For: Oct 28 Filed by: Jarry Olivier Roger
Low
Report
Form 3 OS Therapies Inc For: Oct 28 Filed by: Jarry Olivier Roger
10/29
04:11 pm
ostx
Form 3 OS Therapies Inc For: Oct 28 Filed by: McKean-Dieser Avril Suzette
Low
Report
Form 3 OS Therapies Inc For: Oct 28 Filed by: McKean-Dieser Avril Suzette
10/28
04:56 pm
ostx
Form 8-K OS Therapies Inc For: Oct 28
Medium
Report
Form 8-K OS Therapies Inc For: Oct 28
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: